FOXM1 regulates platelet-induced anoikis resistance in pancreatic cancer cells
Overall, these findings suggest that targeting FOXM1 may be a promising therapeutic strategy to interfere with the metastatic progression of pancreatic cancer, which might particularly benefit patients with high blood platelet counts.
Authors
- Helmut Laumen (ORCID: https://orcid.org/0000-0002-5885-5242)
- Beate Heydel
- Carolin T. Neu (ORCID: https://orcid.org/0009-0009-3238-8541)
- Monika Haemmerle (ORCID: https://orcid.org/0000-0003-3145-0541)
- Tony Gutschner (ORCID: https://orcid.org/0000-0002-1722-3134)
- Ferdinand Krannich
- Alissa Ernesti-Soldatkin
Institutions
- Martin Luther University Halle-Wittenberg (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Cell Communication and Signaling
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1186/s12964-025-02644-8
- Primary Topic
- FOXO transcription factor regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00